These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 7844562)
1. Protection of hamsters against experimental mumps virus (MuV) infection by antibodies raised against the MuV surface glycoproteins expressed from recombinant vaccinia virus vectors. Houard S; Varsanyi TM; Milican F; Norrby E; Bollen A J Gen Virol; 1995 Feb; 76 ( Pt 2)():421-3. PubMed ID: 7844562 [TBL] [Abstract][Full Text] [Related]
2. Recombinant mumps viruses expressing the batMuV fusion glycoprotein are highly fusion active and neurovirulent. Krüger N; Sauder C; Hoffmann M; Örvell C; Drexler JF; Rubin S; Herrler G J Gen Virol; 2016 Nov; 97(11):2837-2848. PubMed ID: 27590163 [TBL] [Abstract][Full Text] [Related]
3. Novel polyvalent live vaccine against varicella-zoster and mumps virus infections. Matsuura M; Somboonthum P; Murakami K; Ota M; Shoji M; Kawabata K; Mizuguchi H; Gomi Y; Yamanishi K; Mori Y Microbiol Immunol; 2013 Oct; 57(10):704-14. PubMed ID: 23905963 [TBL] [Abstract][Full Text] [Related]
4. Functional properties and genetic relatedness of the fusion and hemagglutinin-neuraminidase proteins of a mumps virus-like bat virus. Krüger N; Hoffmann M; Drexler JF; Müller MA; Corman VM; Sauder C; Rubin S; He B; Örvell C; Drosten C; Herrler G J Virol; 2015 Apr; 89(8):4539-48. PubMed ID: 25741010 [TBL] [Abstract][Full Text] [Related]
5. A 176 amino acid polypeptide derived from the mumps virus HN ectodomain shows immunological and biological properties similar to the HN protein. Herrera E; Barcenas P; Hernández R; Méndez A; Pérez-Ishiwara G; Barrón B Virol J; 2010 Aug; 7():195. PubMed ID: 20727167 [TBL] [Abstract][Full Text] [Related]
6. Protective effects of monoclonal antibodies against parainfluenza virus type 3-induced brain infection in hamsters. Rydbeck R; Löve A; Norrby E J Gen Virol; 1988 May; 69 ( Pt 5)():1019-24. PubMed ID: 2836547 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies against the glycoproteins of mumps virus: fusion inhibition by anti-HN monoclonal antibody. Tsurudome M; Yamada A; Hishiyama M; Ito Y J Gen Virol; 1986 Oct; 67 ( Pt 10)():2259-65. PubMed ID: 3760826 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the relative roles of the F and HN surface glycoproteins of the paramyxovirus simian virus 5 in inducing protective immunity. Paterson RG; Lamb RA; Moss B; Murphy BR J Virol; 1987 Jun; 61(6):1972-7. PubMed ID: 3573154 [TBL] [Abstract][Full Text] [Related]
9. Serologic Cross-Reactivity between the Mumps Virus Vaccine Genotype A Strain and the Circulating Genotype G Strain. Shaikh S; Carpenter M; Lin L; Frost JR; McLachlan E; Stein D; Van Caeseele P; Severini A Viruses; 2024 Sep; 16(9):. PubMed ID: 39339910 [TBL] [Abstract][Full Text] [Related]
10. Generation of a recombinant Oka varicella vaccine expressing mumps virus hemagglutinin-neuraminidase protein as a polyvalent live vaccine. Somboonthum P; Yoshii H; Okamoto S; Koike M; Gomi Y; Uchiyama Y; Takahashi M; Yamanishi K; Mori Y Vaccine; 2007 Dec; 25(52):8741-55. PubMed ID: 18053621 [TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of the immunoprotective abilities of glycosylated and deglycosylated parainfluenza virus type 3 surface glycoproteins. Ewasyshyn M; Bonneau AM; Usman S; Scollard N; Klein M J Gen Virol; 1993 Dec; 74 ( Pt 12)():2781-5. PubMed ID: 8277287 [TBL] [Abstract][Full Text] [Related]
12. Lysosome-Associated Membrane Proteins Support the Furin-Mediated Processing of the Mumps Virus Fusion Protein. Ueo A; Kubota M; Shirogane Y; Ohno S; Hashiguchi T; Yanagi Y J Virol; 2020 Jun; 94(12):. PubMed ID: 32295904 [TBL] [Abstract][Full Text] [Related]
13. Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies. Orvell C; Rydbeck R; Löve A J Gen Virol; 1986 Sep; 67 ( Pt 9)():1929-39. PubMed ID: 3018131 [TBL] [Abstract][Full Text] [Related]
14. Protective effect of monoclonal antibodies to Newcastle disease virus in passive immunization. Umino Y; Kohama T; Sato TA; Sugiura A J Gen Virol; 1990 May; 71 ( Pt 5)():1199-203. PubMed ID: 2345369 [TBL] [Abstract][Full Text] [Related]
15. Construction of vaccinia virus recombinants expressing several measles virus proteins and analysis of their efficacy in vaccination of mice. Wild TF; Bernard A; Spehner D; Drillien R J Gen Virol; 1992 Feb; 73 ( Pt 2)():359-67. PubMed ID: 1538193 [TBL] [Abstract][Full Text] [Related]
16. Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China. Cui A; Zhu Z; Mao N; Si Y; Ma Y; Hu Y; Deng X; Wang L; Zeng L; Zhang Y; Xu W Vaccine; 2018 Sep; 36(38):5725-5731. PubMed ID: 30122648 [TBL] [Abstract][Full Text] [Related]
17. Protection of mice from respiratory Sendai virus infections by recombinant vaccinia viruses. Takao SI; Kiyotani K; Sakaguchi T; Fujii Y; Seno M; Yoshida T J Virol; 1997 Jan; 71(1):832-8. PubMed ID: 8985426 [TBL] [Abstract][Full Text] [Related]
18. Cross-neutralization between three mumps viruses & mapping of haemagglutinin-neuraminidase (HN) epitopes. Vaidya SR; Dvivedi GM; Jadhav SM Indian J Med Res; 2016 Jan; 143(1):37-42. PubMed ID: 26997012 [TBL] [Abstract][Full Text] [Related]
20. Role of individual glycoproteins of human parainfluenza virus type 3 in the induction of a protective immune response. Ray R; Glaze BJ; Compans RW J Virol; 1988 Mar; 62(3):783-7. PubMed ID: 2828674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]